ChemoMetec A/S Stock

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen 10:59:32 2024-05-23 am EDT 5-day change 1st Jan Change
369.2 DKK +0.05% Intraday chart for ChemoMetec A/S +0.33% -4.85%
Sales 2024 * 404M 58.67M Sales 2025 * 461M 66.85M Capitalization 6.42B 932M
Net income 2024 * 127M 18.43M Net income 2025 * 153M 22.2M EV / Sales 2024 * 15 x
Net cash position 2024 * 338M 49.04M Net cash position 2025 * 396M 57.51M EV / Sales 2025 * 13.1 x
P/E ratio 2024 *
50.4 x
P/E ratio 2025 *
42 x
Employees 171
Yield 2024 *
1.17%
Yield 2025 *
1.45%
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.03%
1 week+0.33%
Current month+23.48%
1 month+26.79%
3 months-20.74%
6 months+2.27%
Current year-4.85%
More quotes
1 week
355.20
Extreme 355.2
377.60
1 month
281.80
Extreme 281.8
377.60
Current year
281.20
Extreme 281.2
554.00
1 year
255.00
Extreme 255
554.00
3 years
255.00
Extreme 255
1 149.00
5 years
134.00
Extreme 134
1 149.00
10 years
3.26
Extreme 3.26
1 149.00
More quotes
Managers TitleAgeSince
Founder 65 96-12-31
Director of Finance/CFO - 22-10-31
Chief Tech/Sci/R&D Officer - 07-08-31
Members of the board TitleAgeSince
Director/Board Member 62 14-09-30
Founder 65 96-12-31
Director/Board Member 48 -
More insiders
Date Price Change Volume
24-05-23 369.2 +0.05% 70 576
24-05-22 369 +2.67% 43,724
24-05-21 359.4 -0.33% 42,941
24-05-17 360.6 -2.01% 77,492
24-05-16 368 +0.93% 134,545

Delayed Quote Nasdaq Copenhagen, May 23, 2024 at 10:59 am EDT

More quotes
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
369 DKK
Average target price
437.5 DKK
Spread / Average Target
+18.56%
Consensus